Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease
Related Experiment Video
Updated: Apr 4, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Keith Richard Mitchelson1, Wen-Yan Qin1
1Keith Richard Mitchelson, Wen-Yan Qin, National Engineering Research Centre for Beijing Biochip Technology, Beijing 102206, China.
Abstract:
MicroRNAs are small non-coding RNAs that participate in different biological processes, providing subtle combinational regulation of cellular pathways, often by regulating components of signalling pathways. Aberrant expression of miRNAs is an important factor in the development and progression of disease. The canonical myomiRs (miR-1, -133 and -206) are central to the development and health of mammalian skeletal and cardiac muscles, but new findings show they have regulatory roles in the development of other mammalian non-muscle tissues, including nerve, brain structures, adipose and some specialised immunological cells. Moreover, the deregulation of myomiR expression is associated with a variety of different cancers, where typically they have tumor suppressor functions, although examples of an oncogenic role illustrate their diverse function in different cell environments. This review examines the involvement of the related myomiRs at the crossroads between cell development/tissue regeneration/tissue inflammation responses, and cancer development.
Insights
MicroRNAs regulate cellular pathways and disease development. This review explores myomiRs
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression and cellular pathways.
- Aberrant miRNA expression is linked to disease development and progression.
- MyomiRs (miR-1, -133, -206) are crucial for muscle development and health.
Purpose of the Study:
- To review the multifaceted roles of myomiRs beyond muscle tissues.
- To examine myomiR involvement in cell development, tissue regeneration, and inflammation.
- To investigate the association of myomiR deregulation with cancer development and progression.
Main Methods:
- Literature review of studies on myomiR function and expression.
- Analysis of myomiR roles in non-muscle tissues, including neural, adipose, and immune cells.
- Examination of myomiR involvement in cancer, considering both tumor suppressor and oncogenic functions.
Main Results:
- MyomiRs exhibit regulatory roles in diverse non-muscle tissues, impacting development and function.
- MyomiR deregulation is implicated in various cancers, often acting as tumor suppressors.
- Evidence suggests both tumor suppressor and oncogenic roles for myomiRs depending on the cellular context.
Conclusions:
- MyomiRs are key regulators at the intersection of tissue development, regeneration, inflammation, and cancer.
- Understanding myomiR functions in different cellular environments is crucial for therapeutic strategies.
- Further research is needed to fully elucidate the complex roles of myomiRs in health and disease.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Master Transcription Regulators
Mitogens and the Cell Cycle
Mitogens and the Cell Cycle

